Galera Therapeutics (GRTX) has shared an update.
Galera is set to dissolve and wind up its business, a decision made by the Board to benefit the shareholders. A special meeting for stockholder approval of the liquidation plan is scheduled for October 17, 2024. Although the CFO’s position was eliminated to cut costs, he will continue to assist with the wind-up. Investors are encouraged to read the upcoming proxy statement for detailed information on the dissolution process.
See more data about GRTX stock on TipRanks’ Stock Analysis page.
